Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Emre

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Annals of Hematology|September 4, 2016
Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpuraAhmet Emre Eskazan
Haematologica|April 3, 2025
Lowering the platelet count threshold to 40x10<sup>9</sup>/L for lumbar puncture: can this represent a generalized approach? Comment on: "40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies"Ahmet Emre Eşkazan
British Journal of Haematology|August 22, 2025
Refining the risk stratification in advanced-stage classical Hodgkin lymphoma: A critical analysis of clinical prediction modelsOguzhan Koca, Ahmet Emre Eskazan
Korean Journal of Family Medicine|January 8, 2019
Epileptic Seizure Due to Disulfiram TreatmentHabib Erensoy, Ahmet Emre Sargin
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 16, 2004
Case report: malignant teratoma of the sinonasal tractTaner Yilmaz, Ahmet Emre Süslü
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2015
Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpaşa experienceAhmet Emre Eskazan, Teoman Soysal
British Journal of Clinical Pharmacology|August 31, 2019
New drugs approved for acute myeloid leukaemia in 2018Selin Kucukyurt, Ahmet Emre Eskazan
Drug Design, Development and Therapy|May 24, 2019
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpuraTugrul Elverdi, Ahmet Emre Eskazan
Drugs of Today (Barcelona, Spain : 1998)|November 24, 2022
Olverembatinib in chronic myeloid leukemiaRenan Öziskender, Ahmet Emre Eşkazan
Therapeutic Advances in Hematology|October 21, 2017
Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an updateAhmet Emre Eskazan, Dilek Keskin
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Annals of Hematology|September 4, 2016
Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpuraAhmet Emre Eskazan
Haematologica|April 3, 2025
Lowering the platelet count threshold to 40x10<sup>9</sup>/L for lumbar puncture: can this represent a generalized approach? Comment on: "40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies"Ahmet Emre Eşkazan
British Journal of Haematology|August 22, 2025
Refining the risk stratification in advanced-stage classical Hodgkin lymphoma: A critical analysis of clinical prediction modelsOguzhan Koca, Ahmet Emre Eskazan
Korean Journal of Family Medicine|January 8, 2019
Epileptic Seizure Due to Disulfiram TreatmentHabib Erensoy, Ahmet Emre Sargin
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 16, 2004
Case report: malignant teratoma of the sinonasal tractTaner Yilmaz, Ahmet Emre Süslü
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2015
Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpaşa experienceAhmet Emre Eskazan, Teoman Soysal
British Journal of Clinical Pharmacology|August 31, 2019
New drugs approved for acute myeloid leukaemia in 2018Selin Kucukyurt, Ahmet Emre Eskazan
Drug Design, Development and Therapy|May 24, 2019
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpuraTugrul Elverdi, Ahmet Emre Eskazan
Drugs of Today (Barcelona, Spain : 1998)|November 24, 2022
Olverembatinib in chronic myeloid leukemiaRenan Öziskender, Ahmet Emre Eşkazan
Therapeutic Advances in Hematology|October 21, 2017
Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an updateAhmet Emre Eskazan, Dilek Keskin
Pageof 23